Deutsche Bank AG Invests $49.75 Million in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Deutsche Bank acquired 1.68 million Acadia Healthcare shares worth approximately $49.75 million, representing a 1.81% stake, according to its latest SEC filing.
• Acadia Healthcare reported quarterly EPS of $0.38, beating estimates of $0.35, while revenue of $865.84 million also exceeded forecasts. However, revenue declined slightly year over year and the company posted a negative net margin.
• Analysts have raised several price targets, with targets reaching $39–$40, but the overall consensus rating remains “Hold” with a consensus target price of $29.85.

Deutsche Bank AG acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,684,607 shares of the company's stock, valued at approximately $49,746,000. Deutsche Bank AG owned 1.81% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the business. Clough Capital Partners L P purchased a new stake in shares of Acadia Healthcare during the first quarter worth $5,359,000. Bank of America Corp DE boosted its holdings in Acadia Healthcare by 64.7% in the first quarter. Bank of America Corp DE now owns 1,231,172 shares of the company's stock valued at $28,797,000 after purchasing an additional 483,649 shares during the period. Royal Bank of Canada boosted its holdings in Acadia Healthcare by 7,896.1% in the first quarter. Royal Bank of Canada now owns 278,265 shares of the company's stock valued at $6,508,000 after purchasing an additional 274,785 shares during the period. Prescott Group Capital Management L.L.C. acquired a new position in Acadia Healthcare during the 4th quarter worth $2,838,000. Finally, Sei Investments Co. increased its holdings in Acadia Healthcare by 39.0% during the 1st quarter. Sei Investments Co. now owns 316,398 shares of the company's stock worth $7,401,000 after purchasing an additional 88,841 shares during the period.

Acadia Healthcare Trading Down 1.4%

NASDAQ:ACHC opened at $26.97 on Friday. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The stock has a market cap of $2.51 billion, a P/E ratio of -2.17, a P/E/G ratio of 8.86 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a 50-day simple moving average of $29.91 and a 200-day simple moving average of $25.48.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business's quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the company earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ACHC shares. Guggenheim lifted their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. UBS Group upped their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 9th. TD Cowen raised their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 price target for the company in a research note on Monday, May 4th. Finally, KeyCorp boosted their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source